Tech Company Financing Transactions
Linio Biotech Funding Round
Private investors participated in a $4.6 million Seed capital raise for Linio Biotech. The round closed on 11/23/2023.
Transaction Overview
Company Name
Announced On
11/23/2023
Transaction Type
Venture Equity
Amount
$4,590,000
Round
Seed
Investors
Proceeds Purpose
It helps skin naturally regenerate itself by accelerating its natural healing process and can be used to repair various skin defects, such as signs of ageing or unwanted visible scars.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Maria01/Lapinlahdenkatu 16
Helsinki, 00180
FI
Helsinki, 00180
FI
Phone
Website
Email Address
Overview
Linio Biotech is a biotechnology platform company dedicated to developing novel solutions that significantly improve the lives of people suffering from skin defects and aged skin. World's first cell-free sterile tissue product for tissue regeneration is a result of more than a decade of research and development and will challenge the market for regenerative tissue treatments. A driven and competent international team is committed to taking this new core technology to the global market.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Karita Reijonsaari
Chief Marketing Officer
Timo Ylikomi
Chief Operating Officer
Riina Uusmies
Browse more venture capital transactions:
Prev: 11/23/2023: Alpheya venture capital transaction
Next: 11/23/2023: FrontEdge venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs